Movement Alert｜DaVita HealthCare Partners Falls 5.01% in Regular Trading, Unchanged Full-Year Guidance and Berkshire Stake Reduction Continue to Weigh

Market Focus08-07

On August 7, DaVita HealthCare Partners declined 5.01% in regular trading, trading at $179.23/share with turnover of $192 million, extending the sell-off that began earlier in the week.

The stock continues to face pressure from multiple headwinds. While the company reported Q2 adjusted EPS of $4.02, beating the consensus estimate of $3.88 by 3.6% and representing a 36.27% year-over-year increase, management maintained its full-year adjusted EPS guidance at $14.10 to $15.20. The guidance midpoint of $14.65 remains below the market consensus of $14.88, and given consecutive strong beats in Q1 and Q2, the unchanged outlook is being interpreted as a signal of decelerating earnings growth in the second half.

Additionally, SEC filings revealed that Berkshire Hathaway sold 183,000 shares at an average price of $199.55, while Bank of America set a target price of $170, below the current trading level. These combined negatives continue to suppress the stock price.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1170135880?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-07 03:37","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1170135880","market":"us","top_or_hot":-1,"title":"Movement Alert｜DaVita HealthCare Partners Falls 5.01% in Regular Trading, Unchanged Full-Year Guidance and Berkshire Stake Reduction Continue to Weigh","media":"Market Focus","content":"<p><p>On August 7, DaVita HealthCare Partners declined 5.01% in regular trading, trading at $179.23/share with turnover of $192 million, extending the sell-off that began earlier in the week.</p><p>The stock continues to face pressure from multiple headwinds. While the company reported Q2 adjusted EPS of $4.02, beating the consensus estimate of $3.88 by 3.6% and representing a 36.27% year-over-year increase, management maintained its full-year adjusted EPS guidance at $14.10 to $15.20. The guidance midpoint of $14.65 remains below the market consensus of $14.88, and given consecutive strong beats in Q1 and Q2, the unchanged outlook is being interpreted as a signal of decelerating earnings growth in the second half.</p><p>Additionally, SEC filings revealed that Berkshire Hathaway sold 183,000 shares at an average price of $199.55, while Bank of America set a target price of $170, below the current trading level. These combined negatives continue to suppress the stock price.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜DaVita HealthCare Partners Falls 5.01% in Regular Trading, Unchanged Full-Year Guidance and Berkshire Stake Reduction Continue to Weigh</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜DaVita HealthCare Partners Falls 5.01% in Regular Trading, Unchanged Full-Year Guidance and Berkshire Stake Reduction Continue to Weigh\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-08-07 03:37</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On August 7, DaVita HealthCare Partners declined 5.01% in regular trading, trading at $179.23/share with turnover of $192 million, extending the sell-off that began earlier in the week.</p><p>The stock continues to face pressure from multiple headwinds. While the company reported Q2 adjusted EPS of $4.02, beating the consensus estimate of $3.88 by 3.6% and representing a 36.27% year-over-year increase, management maintained its full-year adjusted EPS guidance at $14.10 to $15.20. The guidance midpoint of $14.65 remains below the market consensus of $14.88, and given consecutive strong beats in Q1 and Q2, the unchanged outlook is being interpreted as a signal of decelerating earnings growth in the second half.</p><p>Additionally, SEC filings revealed that Berkshire Hathaway sold 183,000 shares at an average price of $199.55, while Bank of America set a target price of $170, below the current trading level. These combined negatives continue to suppress the stock price.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"DVA","symbol_name":"达维塔保健","start_time":0,"source_url":"","article_id":"1170135880","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1170135880","pubTimestamp":1786045035,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On August 7, DaVita HealthCare Partners declined 5.01% in regular trading, trading at $179.23/share with turnover of $192 million, extending the sell-off that began earlier in the week.The stock...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"DVA":"达维塔保健"},"translate_title":"走势警报|DaVita HealthCare Partners 常规交易中下跌 5.01%，全年指引不变，伯克希尔减持继续承压","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DVA":1},"content_text":"On August 7, DaVita HealthCare Partners declined 5.01% in regular trading, trading at $179.23/share with turnover of $192 million, extending the sell-off that began earlier in the week.The stock continues to face pressure from multiple headwinds. While the company reported Q2 adjusted EPS of $4.02, beating the consensus estimate of $3.88 by 3.6% and representing a 36.27% year-over-year increase, management maintained its full-year adjusted EPS guidance at $14.10 to $15.20. The guidance midpoint of $14.65 remains below the market consensus of $14.88, and given consecutive strong beats in Q1 and Q2, the unchanged outlook is being interpreted as a signal of decelerating earnings growth in the second half.Additionally, SEC filings revealed that Berkshire Hathaway sold 183,000 shares at an average price of $199.55, while Bank of America set a target price of $170, below the current trading level. These combined negatives continue to suppress the stock price.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1170135880","isCrawlerRequest":true}